Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 676-405-7 | CAS number: 165253-31-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 015
- Report date:
- 2015
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- 1-(oxolan-3-yl)methanamine
- EC Number:
- 676-405-7
- Cas Number:
- 165253-31-6
- Molecular formula:
- C5 H11 N O
- IUPAC Name:
- 1-(oxolan-3-yl)methanamine
- Reference substance name:
- 3-Aminomethyl-THF
- IUPAC Name:
- 3-Aminomethyl-THF
- Details on test material:
- - Name of test material (as cited in study report): 3-Aminomethyl-THF
- Physical state: liquid, colorless, clear
- Analytical purity: 99.9%
- Lot/batch No.: 069/2013 Fr.3 Fl.2
Constituent 1
Constituent 2
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories Germany GmbH
- Age at study initiation: 5 - 8 weeks
- Weight at study initiation: 29.4 g (mean)
- Assigned to test groups randomly: yes
- Housing: single housing (polycarbonate cages, type II)
- Diet (e.g. ad libitum): Standardized pelleted feed (Maus/Ratte Haltung "GLP", Provimi Kliba SA, Kaiseraugst, Switzerland)
- Water (e.g. ad libitum): ad libitum
- Acclimation period: al least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 - 24 °C
- Humidity (%): 30 - 70 %
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: water
- Justification for choice of solvent/vehicle: good solubility of the test substance - Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
The test substance was dissolved at dose levels of 300, 600 and 1200 mg/kg bw (prepared immediately before administration) - Duration of treatment / exposure:
- 24 and 48 Hours
- Frequency of treatment:
- single application
Doses / concentrations
- Remarks:
- Doses / Concentrations:
300, 600 and 1200 mg/kg bw
Basis:
actual ingested
- No. of animals per sex per dose:
- 5 aminals per dose
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- cyclophosphamide
- Route of administration: orally
- Doses / concentrations: 20 mg/kg bw.
Examinations
- Tissues and cell types examined:
- Bone marrow
- Details of tissue and slide preparation:
- Pretests for dose selection:
In the pretest to determine the acute oral toxicity in males and females, one male animal died at 2 000 mg/kg body weight. All surviving animals showed severe signs of toxicity. At 1 500 mg/kg, all animals survived with severe signs of toxicity. However, there were no distinct differences in clinical observations between male and female animals. Thus, only male animals will be used in the main experiment.
Test substance concentrations:
The low dose group was given 300 mg/kg body weight or 10 mL/kg body weight of a test substance solution with a concentration of 30 mg/mL.
The intermediate dose group was given 600 mg/kg body weight or 10 mL/kg body weight of a test substance solution with a concentration of 60 mg/mL.
The top dose group was given 1 200 mg/kg body weight or 10 mL/kg body weight of a test substance solution with a concentration of 120 mg/mL.
Preparation of the bone marrow:
The bone marrow was prepared according to the method described by Schmid (7, 8) and Salamone et al. (6).
- The animals were anesthetized with isoflurane and afterwards sacrificed by cervical dislocation. Then the two femora were prepared by dissection and removing all soft tissues.
- After cutting off the epiphyses, the bone marrow was flushed out of the diaphysis into a centrifuge tube using a cannula filled with fetal calf serum (FCS) which was preheated up to 37°C (about 2 mL/femur).
- The suspension was mixed thoroughly with a pipette and centrifuged at 300 x g for 5 minutes. The supernatant was removed and the precipitate was resuspended in about 50 μL fresh FCS.
- One drop of this suspension was dropped onto clean microscopic slides, using a Pasteur pipette. Smears were prepared using slides with ground edges. The preparations were dried in the air and subsequently stained.
Staining of the slides:
The slides were stained with eosin and methylene blue for about 5 minutes. After briefly rinsing in deionized water, the preparations were soaked in deionized water for about 2 - 3 minutes. Subsequently, the slides were stained with Giemsa solution for about 15 minutes. After rinsing twice in deionized water and clarifying in xylene, the preparations were mounted in Corbit-Balsam. - Evaluation criteria:
- In general, 2 000 polychromatic erythrocytes (PCE) were evaluated for the occurrence of micronuclei from each animal of every test group, so in total 10 000 PCEs were scored per test group. The normochromatic erythrocytes (= normocytes / NCE) were also scored. The following parameters were recorded:
Number of polychromatic erythrocytes.
Number of polychromatic erythrocytes containing micronuclei.
The increase in the number of micronuclei in polychromatic erythrocytes of treated animals as compared with the vehicle control group provides an index of a chromosome-breaking (clastogenic) effect or damage of the mitotic apparatus (aneugenic activity) of the test substance administered.
Number of normochromatic erythrocytes.
Number of normochromatic erythrocytes containing micronuclei.
The number of micronuclei in normochromatic erythrocytes at the early sacrifice interval shows the situation before test substance administration and may serve as a control value. A test substance induced increase in the number of micronuclei in normocytes may be found with an increase in the duration of the sacrifice interval.
Ratio of polychromatic to normochromatic erythrocytes.
An alteration of this ratio indicates that the test substance actually reached the bone marrow, means the target determined for genotoxic effects.
Number of small micronuclei (d < D/4) and of large micronuclei (d ≥ D/4) [d = diameter of micronucleus, D = cell diameter]. The size of micronuclei may indicate the possible mode of action of the test substance (9), i.e. a clastogenic effect (d < D/4) or a spindle poison effect (d ≥ D/4). - Statistics:
- The statistical evaluation of the data was carried out using the program system MUKERN (BASF SE). The asymptotic U test according to MANN-WHITNEY (modified rank test according to WILCOXON) was carried out to clarify the question whether there are statistically significant differences between the untreated control group and the treated dose groups with regard to the micronucleus rate in polychromatic erythrocytes. The relative frequencies of cells containing micronuclei of each animal were used as a criterion for the rank determination for the U test. Statistical significances were identified as follows:
* p ≤ 0.05
** p ≤ 0.01
However, both biological relevance and statistical significance were considered together.
Results and discussion
Test results
- Sex:
- male
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- Main Test:
The single oral administration of the vehicle deionized water in a volume of 10 mL/kg body weight led to 1.3‰ polychromatic erythrocytes containing micronuclei after either the 24-hour or 48-hour sacrifice interval.
After the single administration of the highest dose of 1 200 mg/kg body weight, 1.1‰ polychromatic erythrocytes containing micronuclei were found after 24 hours and 1.6‰ after 48 hours.
In the two lower dose groups, rates of micronuclei of 0.8‰ (600 mg/kg group) and 1.4‰ (300 mg/kg group) were detected at a sacrifice interval of 24 hours in each case.
The positive control substance cyclophosphamide led to a statistically significant increase (17.3‰) in the number of polychromatic erythrocytes containing mainly small micronuclei, as expected.
The number of normochromatic erythrocytes containing micronuclei did not differ to any appreciable extent in the vehicle control group or in the various dose groups at any of the sacrifice intervals.
A slight inhibition of erythropoiesis determined from the ratio of polychromatic to normochromatic erythrocytes was detected after test substance administration at 48-hour sacrifice interval (1 200 mg/kg body weight; portion of PCEs: 85% of the concurrent vehicle control). Thus, bioavailability of the test substance after oral administration in blood and bone marrow was confirmed.
Clinical examinations:
The single oral administration of the vehicle in a volume of 10 mL/kg body weight was tolerated by all animals without any clinical observations.
The administration of the test substance led to distinct clinical signs of toxicity. At 600 mg/kg body weight hunched posture was observed. At 1 200 mg/kg body weight the animals showed hunched posture and piloerection.
Neither the single administration of the positive control substance cyclophosphamide in a dose of 20 mg/kg body weight caused any evident signs of toxicity.
Any other information on results incl. tables
Induction of Micronuclei in bone marrow cells
Test group |
Sacrifice interval [hrs] |
Animal No. |
Miconuclei in PCE |
PCEs per 2000 erythrocytesc |
|
totala [‰] |
Large MNb [‰] |
||||
Vehicle control Deionized water |
24 |
5 |
1.3 |
0.0 |
1327 |
Test substance 300 mg/kg bw. |
24 |
5 |
1.4 |
0.3 |
1282 |
Test substance 600 mg/kg bw. |
24 |
5 |
0.8 |
0.1 |
1329 |
Test substance 1 200 mg/kg bw. |
24 |
5 |
1.1 |
0.0 |
1274 |
Positive control cyclophosphamide 20 mg/kg bw. |
24 |
5 |
17.3** |
0.1 |
1391 |
Vehicle control Deionized water |
48 |
5 |
1.3 |
0.0 |
1370 |
Test substance 1 200 mg/kg bw. |
48 |
5 |
1.6 |
0.0 |
1167 |
PCE = polychromatic erythrocytes
NCE = normochromatic erythrocytes
bw. = body weight
a = sum of small and large micronuclei
b = large micronuclei (indication for spindle poison effect)
c = calculated number of PCEs per 2 000 erythrocytes (PCE + NCE) when
scoring a sample of up to 10 000 PCE per test group
* = p ≤ 0.05
** = p ≤ 0.01
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.